Evidence map›Paper›PMID 41723422›Full record

ArticleBMC medical informatics and decision making2026

Development and psychometric evaluation of a decision quality instrument for lung cancer screening decisions (DQI-LCS).

Naomi Q P Tan, Maria A Lopez-Olivo, Tito R Mendoza, Laura C Crocker, Karen R Sepucha, Shawn P E Nishi, Robert J Volk, Lisa M Lowenstein

Abstract read
In one paragraph

Article in BMC medical informatics and decision making, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Naomi Q P TanRutgers Cancer Institute, New Brunswick, NJ, USA.
Maria A Lopez-OlivoDepartment of Health Services Research, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Tito R MendozaOffice of Patient-Centered Outcomes Research, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
Laura C CrockerDepartment of Health Services Research, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Karen R SepuchaHealth Decision Sciences Center, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Shawn P E NishiDepartment of Internal Medicine, Division of Pulmonary Critical Care and Sleep Medicine, The University of Texas Medical Branch, Galveston, TX, USA.
Robert J VolkDepartment of Health Services Research, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Lisa M LowensteinDepartment of Health Services Research, University of Texas MD Anderson Cancer Center, Houston, TX, USA. lmlowenstein@mdanderson.org.

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI DIANE BODURKA · 1985 to 2026
$290.8M
TRANSCRIPTIONAL PROFILINGP30CA072720 · NCI · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI Tracie Saunders · 1997 to 2026
$94.5M
Cancer Prevention and Research Institute of Texas RP160674NCI NIH HHS P30CA016672NCI NIH HHS P30CA072720
6 · The paper itself

Abstract

backgroundLung cancer screening (LCS) reduces lung cancer mortality among high-risk individuals. As the screening procedure has both potential benefits and harms, the Centers for Medicare & Medicaid Services mandates a shared decision-making (SDM) discussion prior to the initial LCS. We evaluated the psychometric properties of a decision quality instrument for LCS (DQI-LCS) that assesses whether patients (1) were informed about their options (knowledge), (2) made a screening decision in line with their preferences (goal concordance), and (3) underwent an optimal SDM process (measured using the SDM Process measure [SDMP_4]).

methodsSecondary analysis of survey data with patients who underwent LCS at tertiary care medical centers in the US within 12 months of the survey. Psychometric evaluation examined the DQI knowledge measure for item retention and deletion, feasibility, test-retest reliability, and validity of the three components of the DQI-LCS.

resultsThe final sample (N = 264) was 48.0% female and had a mean age of 64.8. One knowledge item (KQ13) was dropped as it had a poor index of discrimination, resulting in a 15-item LCS knowledge measure (LCS-15). We also developed a brief knowledge measure with 5 items (LCS-5). Overall, the DQI-LCS was feasible to complete (under 5% missing data for all items). However, only the overall LCS-15 knowledge measure had acceptable test-retest reliability. The SURE score was positively associated with knowledge, demonstrating construct validity of the knowledge component. When there was goal concordance, there was a greater probability of the participant reporting that they would make the same decision again and be screened every year, demonstrating predictive validity of the goal concordance measure. Finally, higher SDMP_4 scores were associated with higher SURE scores, demonstrating predictive validity of SDMP_4. However, we did not find concurrent validity of SDMP_4 with CollaboRATE.

conclusionsOverall, there is evidence that the DQI-LCS was feasible to complete, had moderate test-retest reliability, and acceptable construct and predictive validity. A limitation is that our sample only included people who had undergone LCS. With further evaluation, the validated DQI-LCS can be a quality metric for assessing whether patients are receiving guideline-concordant care for LCS.

Indexed as

Decision Making, SharedEarly Detection of CancerLung NeoplasmsPatient ParticipationPsychometricsAgedFemaleHumansMaleMiddle AgedReproducibility of ResultsSurveys and QuestionnairesDecision quality instrumentLung cancer screeningPsychometric evaluationQuality measure

Identifiers

PMID41723422
PMCPMC13032454

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.